Colorado Drew the Line: What HB 1195 Actually Prohibits and Why the State-Board Pincer Just Got a Statute
Colorado just handed its licensing boards a statute for clinical-AI enforcement, turning the state-board pincer from theory into law.
On June 3, Governor Jared Polis signed HB 26-1195, making Colorado the first state to write into statute what a licensed clinician cannot let an AI system do — and to attach licensing-board discipline to the answer. The bill blocks AI from talking to clients as therapy, from generating treatment plans without clinician review, and from claiming to detect emotions or mental states. That last one is the surprise.
The mechanism is narrower than headlines will make it sound. Psychologists, counselors, social workers, marriage and family therapists, addiction counselors, and unlicensed psychotherapists cannot use an AI system to interact with clients in therapeutic communication without synchronous, real-time involvement of the clinician; cannot let AI generate therapeutic recommendations or treatment plans without clinician review; and cannot use AI to detect emotions or mental states. Administrative support, scheduling, and note-drafting are fine — as long as the clinician keeps full responsibility for the outputs.
The emotion-detection clause is the one to watch. A growing pile of vendor pitches — affect recognition from voice, facial-coding overlays on telehealth, sentiment scoring on session transcripts — gets caught by a single sentence. Colorado didn't bother arguing whether those systems work. It just said a licensed clinician can't run them on a client.
Then the bill turns outward. It is unlawful to provide, advertise, or offer psychotherapy services in the state — including through an AI system — unless the services come from a regulated professional. It is an unfair trade practice under the Colorado Consumer Protection Act for an AI product's advertising, interface, or outputs to imply its responses are endorsed by or equivalent to psychotherapy, or to claim user data is confidential when it isn't. That second sentence is doing real work. It folds the AI-as-therapist marketing problem into the same consumer-protection statute Colorado already uses against other deceptive health claims, which means the Attorney General can move without waiting for a private plaintiff.
This is the second time in a week Colorado has been the test case here, and the pattern is becoming legible. Federal evaluation infrastructure — CAISI, VERA-MH, FDA's SaMD pathway — exists, but it moves on federal timelines. State licensure boards already meet monthly and already discipline clinicians who practice outside their scope. HB 1195 gives those boards a statutory hook for clinical AI specifically, which is the state-board pincer route that's been visible in outline for months. Now it has a citation.
A few things HB 1195 deliberately does not do. It doesn't ban self-help apps, journaling tools, mood trackers, or guided-meditation products, as long as they disclose they aren't clinical care. It doesn't reach research conducted under an IRB. It doesn't try to regulate the underlying models. The legislature kept the scope tight on purpose — the bill's own text reminds readers that Colorado's psychotherapy definition is meant to be read narrowly.
For anyone building or buying a clinical AI product, the operational question shifts. It is no longer "will the FDA classify this as a device." It is "which state licensing board will be the first to discipline a clinician for using our product, and what does our contract say about that." Colorado just made the answer to the second question concrete.
The translation problem HB 1195 is trying to handle — when does an AI output count as a treatment plan, when does an affect score count as detecting a mental state — is exactly the measurement gap Metonym is building the Salient Distress Model to address. A statute can draw the line; somebody still has to evaluate whether a given product crossed it.
Metonym Clinical AI Intelligence — regulatory analysis at the intersection of clinical evaluation and AI safety. Produced under the Metonym Standard. Informational only — not legal advice, not clinical advice.